Skip to content
DataLookout
Menu

RESYSTAANCT05391113

REward SYSTem in Autism Spectrum Disorder and Addictive Disorder

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 9 versions: 9 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Jul 2028
    • Eligibility criteria expanded, about 13 words
    • Site contacts updated at 3 of 3 sites
    • Collaborator revised
  2. Minor Site contacts updated at 3 of 3 sitesv8
  3. Notable Trial status: Not Yet Recruiting to Recruitingv7 Show 4 more changesShow less
    • Primary completion date: May 15, 2026 to Jul 27, 2026
    • Study completion date: Oct 1, 2026 to Jan 27, 2027
    • Start date changed from estimate of May 15, 2023 to Jul 27, 2023
    • Site details revised at 3 of 3 sites
  4. Notable Start date: Apr 1, 2023 to May 15, 2023
    • Primary completion date: Apr 1, 2026 to May 15, 2026
    v6
  5. Notable Start date: Mar 1, 2023 to Apr 1, 2023v5 Show 4 more changesShow less
    • Enrollment target: 54 to 78
    • Primary completion date: Mar 1, 2026 to Apr 1, 2026
    • Study completion date: Sep 1, 2026 to Oct 1, 2026
    • Interventions: MRI (Diagnostic Test) to EEG (Diagnostic Test), MRI (Diagnostic Test)
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Start date: Nov 9, 2022 to Mar 1, 2023
    • Eligibility criteria shortened, about 6 words
    • Primary completion date: Nov 9, 2025 to Mar 1, 2026
    • Study completion date: Jan 9, 2026 to Sep 1, 2026
    v4
  2. Notable Start date: Sep 15, 2022 to Nov 9, 2022
    • Primary completion date: Sep 15, 2025 to Nov 9, 2025
    • Study completion date: Sep 16, 2025 to Jan 9, 2026
    v3
  3. Minor Study sites: 2 to 3v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Blood Oxygene Level Dependent (BOLD) MRI signal
Timeframe: At inclusion

Secondary (2)

Tolerance to an MRI examination for FAD with overweight or obesity
Regulation of sensory, an fMRI measurement of the BOLD physiological signal for sensory responses (sensory block) in terms of brain activation in patients

Arms and interventions

Autism Spectrum DisorderExperimental

Characterized by two main diagnostic criteria: a socio-emotional deficit via a defect in communication and social reciprocity, and a behavioral deficit which manifests itself in repetitive behavioral patterns (stereotypes), restricted interests and/or activities.

Food Addictive DisordersActive comparator

Characterized by regroup substance use disorders and behavioral addictions, are characterized in particular by the repeated occurrence of compulsive behavior and impaired social functioning

Healthy volonteersPlacebo comparator

Adult without neurological and psychiatric history, absence of progressive somatic pathologies or with vital risk.

Diagnostic tests: MRI, EEG

Sites

3 sites in 1 country